BrokerCheck records show $2.7 million arbitration award against Merrill Lynch in case involving broker Chelsea Deng and private placement claims

If you invested in private placements through a Merrill Lynch advisor and lost money, the outcome of a recent FINRA arbitration may be worth your attention. BrokerCheck records show that Chelsea Deng (CRD# 4179306), currently registered with Morgan Stanley in Beverly Hills, California, was a named subject of a customer complaint that resulted in a $2,727,527.31 arbitration award against her former firm, Merrill Lynch, Pierce, Fenner & Smith Incorporated. The award, rendered on July 7, 2025, also included $954,634.56 in attorneys’ fees and $2,002.25 in costs. The underlying complaint arose from conduct during Deng’s tenure at Merrill Lynch, not at Morgan Stanley.

Deng’s BrokerCheck record contains one disclosed customer dispute, which resulted in a final arbitration award in favor of the claimants.

The arbitration and what the claimants alleged

According to BrokerCheck, FINRA Case #23-03422 was filed on November 30, 2023. The claimants sought $3,500,000 in alleged damages.

The regulator’s version of the disclosure states that “Deng was a subject of the customer’s complaint against her member firm that asserted the following causes of action: violation of the relevant securities acts and laws; equity; violations of industry standards; breach of fiduciary duty; negligence; negligent supervision; and breach of contract. The causes of action relate to various unspecified securities.”

The firm’s version identifies the product type as private placements and summarizes the allegations as follow: “Clients allege financial advisor made certain misrepresentations and unsuitable investment recommendations.”

According to BrokerCheck, the FINRA arbitration panel rendered its award on July 7, 2025. The disposition detail states that “Deng’s member firm is liable for and shall pay to Claimants the sum of $2,727,527.31 in compensatory damages; is liable for and shall pay to Claimants the sum of $2,002.25 in costs; and is liable for and shall pay to Claimants the sum of $954,634.56 in attorneys’ fees.”

BrokerCheck records show that Deng’s individual contribution to the award was $0.00. The full award was assessed against Merrill Lynch.

In a statement filed with BrokerCheck, Deng stated: “The arbitration award specified an even exchange of a basket of securities for their current statement value and required Merrill to reimburse Claimants for their attorney’s fees and certain costs. The securities at issue were all profitable. I am saddened that this dispute ever occurred and confident that I always acted in my clients’ best interest.”

The complaint arose from conduct at Merrill Lynch, Pierce, Fenner & Smith Incorporated, not at Deng’s current firm, Morgan Stanley.

Private placements and why they generate investor complaints

Private placements are securities sold outside the public markets, typically under Regulation D of the Securities Act. They don’t trade on any exchange, which means investors usually can’t sell them when they want to. That illiquidity is the core problem.

These investments also tend to carry higher fees and commissions than publicly traded alternatives. The offering documents can run hundreds of pages, and the risk disclosures are often buried deep. When a broker recommends a concentrated position in private placements, the investor’s portfolio can become heavily weighted in assets that are hard to value and impossible to liquidate on short notice. FINRA has repeatedly flagged private placements as a source of suitability complaints, particularly when they’re recommended to investors whose risk tolerance, liquidity needs, or investment objectives don’t match the product’s characteristics.

The legal framework that governs these recommendations

The conduct at issue occurred while Deng was registered with Merrill Lynch. For recommendations made before June 30, 2020, FINRA Rule 2111 (the suitability rule) required brokers to have a reasonable basis for believing that a recommended transaction was suitable for the customer, based on the customer’s investment profile. For recommendations made on or after that date, the SEC’s Regulation Best Interest (17 C.F.R. § 240.15l-1) raised the bar, requiring brokers to act in the customer’s best interest at the time a recommendation is made.

The claimants’ causes of action also included breach of fiduciary duty and negligent supervision. FINRA Rule 3110 requires member firms to establish and maintain supervisory systems reasonably designed to achieve compliance with applicable securities laws and regulations. When those systems fall short, the firm can be held liable alongside the individual representative. FINRA Rule 2010 requires brokers and firms to observe high standards of commercial honor and just and equitable principles of trade. Misrepresentation claims implicate this rule directly.

What investors can do

Investors who suffered losses from unsuitable private placement recommendations may be able to recover damages through FINRA arbitration. The typical measure of damages in these cases is out-of-pocket loss: the difference between what the investor paid and what the investment was actually worth. In cases involving concentrated positions, a “well-managed account” analysis can show what the portfolio would have earned under proper management.

FINRA Rule 12206 governs eligibility for arbitration claims. Investors considering a claim should consult with a securities arbitration attorney to evaluate whether their situation falls within the applicable timeframe.

Steps to take right now

1. Gather your account statements, trade confirmations, and any correspondence with your broker or firm, including emails, texts, and written materials about the investments.
2. Look up your broker on FINRA BrokerCheck at brokercheck.finra.org to review their full disclosure record.
3. Contact a securities arbitration attorney for a consultation to evaluate your options.

Rosenberger + Kawabata represents retail investors in FINRA arbitration proceedings involving unsuitable private placement recommendations, misrepresentation, and failure to supervise. Contact Rosenberger + Kawabata online for a free and confidential consultation, or call (310) 894-6921.

The information in this post comes from FINRA’s public BrokerCheck database. You can view the full detailed report (CRD# 4179306) here.